Source: Annual Congress 2007 - Pulmonary hypertension in the clinic



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kawut, M. Krowka, K. Roberts, R. Benza, D. Taichman, D. Badesch, E. Horn, D. Rabinowitz, J. Trotter, L. Forman, R. Brown, M. Fallon (New York, NY, Rochester, MN, Boston, MA, Birmingham, AL, Philadelphia, PA, Denver, CO, United States Of America). A multicenter case-control study of genetic risk factors for portopulmonary hypertension (POPH). Eur Respir J 2007; 30: Suppl. 51, 3278

Member's Comments

No comment yet.

Related content which might interest you: Occupational risk factors for sarcoidosis in a multicenter case-control study Source: Virtual Congress 2020 – Occupational lung diseases Year: 2020 Prevalence and mechanism of pulmonary hypertension in sickle cell disease: a prospective multicentre french study Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013 Source: Eur Respir J , 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016 Year: 2017 Use of bosentan for the treatment of pulmonary arterial hypertension in Spain: a multicenter, retrospective, observational study Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Multi-institutional prospective registry in pulmonary hypertension associated with respiratory disease in Japan. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Identification of risk factors of acute cardiovascular events in acute exacerbation period for patients with COPD: a prospective nested case-control study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy. Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Safety of riociguat for chronic thromboembolic pulmonary hypertension (CTEPH): Interim data from a prospective non-interventional study in Japan Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019 The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003 COPD and its comorbidities – prospective study Source: Eur Respir J 2007; 30: Suppl. 51, 79s Year: 2007 Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China Source: Eur Respir J, 56 (5) 1902157; 10.1183/13993003.02157-2019 Year: 2020 Which cardiovascular diseases are most influenced by smoking – a cohort retrospective study Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation Year: 2019 Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019 A multicentre cohort study on the association between common markers of asthma and the incidence of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 295s Year: 2006 Macitentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH): results from the randomised controlled MERIT study Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study Source: Eur Respir J 2016; 47: 95-103 Year: 2016 Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019 Year: 2019 Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study Source: Eur Respir J, 50 (1) 1700094; 10.1183/13993003.00094-2017 Year: 2017 Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010